7 clinics shown
Dr. Farrukh Jamil operates a psychiatric practice on Goodyear Avenue in Gadsden, providing outpatient mental health services for adults. The practice focuses on psychiatric evaluations and medication management. Specific treatment modalities such as TMS, esketamine, or ketamine therapy are not detailed in available information; prospective patients should inquire directly about specialized treatment options beyond standard psychiatric care.
Gadsden Physician Clinics operates a neurology practice on Medical Center Drive in Gadsden, providing diagnostic and treatment services for neurological conditions. The clinic does not appear to specialize in psychiatric treatments such as TMS therapy, esketamine, or ketamine infusions based on available listing information. Patients seeking treatment-resistant depression care or procedural psychiatric interventions should contact the clinic directly to confirm whether such services are offered or if referrals to appropriate providers can be arranged.
Gadsden Regional Medical Center operates a full-service hospital on Goodyear Avenue in Gadsden, providing inpatient and outpatient medical services to northeast Alabama. The facility's psychiatric and behavioral health offerings are not specified in available listings; patients seeking TMS, esketamine, or ketamine treatments should contact the hospital directly to confirm whether these services are available through its behavioral health department. The medical center accepts most major insurance plans for covered services.
Health Services Center operates a multi-service medical facility on Goodyear Avenue in Gadsden, providing addiction treatment, HIV testing, infectious disease care, and housing assistance for low-income patients. The center functions as a federally qualified health center serving northeast Alabama's underserved populations. Psychiatric services such as TMS or esketamine are not listed among current offerings; patients seeking those treatments should inquire directly or request referrals to specialized providers.
Khusro Clinic provides psychiatric services at its Bay Street location in Gadsden, offering evaluations and medication management for adults with mental health conditions. The practice operates as a general psychiatry office; specific availability of procedural treatments such as TMS or esketamine is not indicated in current listings. Patients seeking specialized interventions for treatment-resistant depression should contact the clinic to confirm which therapeutic options are offered.
Mountain View Hospital operates a psychiatric inpatient facility on Scenic Highway in Gadsden, providing crisis stabilization and acute psychiatric care for adults and adolescents. The hospital admits patients experiencing severe mental health episodes requiring 24-hour medical supervision, including those with mood disorders, psychotic disorders, and suicidal ideation. Treatment typically includes psychiatric evaluation, medication management, individual and group therapy, and discharge planning. Specific procedural treatments such as TMS or esketamine are not detailed in available information.
Riverview Regional Medical Center operates a full-service hospital in downtown Gadsden on South 3rd Street, providing inpatient and outpatient medical care across multiple specialties. As a general hospital, psychiatric services may be available but specific offerings such as TMS therapy, esketamine, or ketamine treatments are not detailed in current listings. Patients seeking mental health treatment should contact the facility directly to confirm whether specialized depression therapies are provided on-site or through affiliated providers.
Spravato is the brand name for esketamine, an FDA-approved nasal spray for treatment-resistant depression and major depressive disorder with suicidal ideation. It's derived from ketamine and works on the brain's glutamate system — a different mechanism than traditional antidepressants like SSRIs.
Treatment is administered only at REMS-certified clinics under direct medical supervision. Patients self-administer the spray under a clinician's guidance, then remain at the clinic for at least two hours of monitoring after each dose. The induction phase typically involves twice-weekly sessions for four weeks, followed by weekly or biweekly maintenance dosing depending on response.
Many patients report meaningful symptom improvement within the first one to two weeks — substantially faster than the 4 to 8 weeks typical of oral antidepressants. Spravato is taken alongside an oral antidepressant, not as a replacement.
The most common side effects are dissociation, dizziness, sedation, and elevated blood pressure during and shortly after dosing. These typically resolve within the two-hour monitoring window. Patients cannot drive on the day of treatment.
Most commercial insurance and Medicare cover Spravato for treatment-resistant depression with prior authorization. Clinics offering Spravato in our directory hold active REMS certification and are staffed to provide the required in-clinic monitoring period.